chr1-1512436-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001170535.3(ATAD3A):c.168G>A(p.Glu56=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00801 in 149,064 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0080 ( 11 hom., cov: 29)
Exomes 𝑓: 0.0079 ( 10 hom. )
Failed GnomAD Quality Control
Consequence
ATAD3A
NM_001170535.3 synonymous
NM_001170535.3 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 2.71
Genes affected
ATAD3A (HGNC:25567): (ATPase family AAA domain containing 3A) This gene encodes a ubiquitously expressed mitochondrial membrane protein that contributes to mitochondrial dynamics, nucleoid organization, protein translation, cell growth, and cholesterol metabolism. This gene is a member of the ATPase family AAA-domain containing 3 gene family which, in humans, includes two other paralogs. Naturally occurring mutations in this gene are associated with distinct neurological syndromes including Harel-Yoon syndrome. High-level expression of this gene is associated with poor survival in breast cancer patients. A homozygous knockout of the orthologous gene in mice results in embryonic lethality at day 7.5 due to growth retardation and defective development of the trophoblast lineage. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 1-1512436-G-A is Benign according to our data. Variant chr1-1512436-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 770482.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.71 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00801 (1194/149064) while in subpopulation AMR AF= 0.0282 (424/15028). AF 95% confidence interval is 0.026. There are 11 homozygotes in gnomad4. There are 584 alleles in male gnomad4 subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 11 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATAD3A | NM_001170535.3 | c.168G>A | p.Glu56= | synonymous_variant | 1/16 | ENST00000378756.8 | NP_001164006.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATAD3A | ENST00000378756.8 | c.168G>A | p.Glu56= | synonymous_variant | 1/16 | 1 | NM_001170535.3 | ENSP00000368031 | P1 | |
ATAD3A | ENST00000378755.9 | c.168G>A | p.Glu56= | synonymous_variant | 1/16 | 2 | ENSP00000368030 | |||
ATAD3A | ENST00000672388.1 | n.272G>A | non_coding_transcript_exon_variant | 1/14 | ||||||
ATAD3A | ENST00000339113.9 | c.54G>A | p.Glu18= | synonymous_variant, NMD_transcript_variant | 1/17 | 2 | ENSP00000339421 |
Frequencies
GnomAD3 genomes AF: 0.00801 AC: 1194AN: 148978Hom.: 11 Cov.: 29
GnomAD3 genomes
AF:
AC:
1194
AN:
148978
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00793 AC: 8500AN: 1071846Hom.: 10 Cov.: 31 AF XY: 0.00803 AC XY: 4075AN XY: 507588
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
8500
AN:
1071846
Hom.:
Cov.:
31
AF XY:
AC XY:
4075
AN XY:
507588
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00801 AC: 1194AN: 149064Hom.: 11 Cov.: 29 AF XY: 0.00802 AC XY: 584AN XY: 72820
GnomAD4 genome
AF:
AC:
1194
AN:
149064
Hom.:
Cov.:
29
AF XY:
AC XY:
584
AN XY:
72820
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 27, 2017 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at